BioCardia, Inc. (BCDA) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $15.00K; Additional Paid in CapitalUSD $174.91M; Retained Earnings (Accumulated Deficit)USD $-172.22M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $11.00K; Additional Paid in CapitalUSD $169.53M; Retained Earnings (Accumulated Deficit)USD $-170.61M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $11.00K; Additional Paid in CapitalUSD $169.23M; Retained Earnings (Accumulated Deficit)USD $-168.35M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $11.00K; Additional Paid in CapitalUSD $168.98M; Retained Earnings (Accumulated Deficit)USD $-166.37M.
BioCardia, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Recognition and Exercise USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $15.00K | $174.91M | $-172.22M | $2.70M | (m) | 3 month · $109.00K | (m) | (m) |
| 2026-03-31 | $0.00 | $11.00K | $169.53M | $-170.61M | $-1.07M | (m) | 3 month · $113.00K | (m) | (m) |
| 2025-12-31 | $0.00 | $11.00K | $169.23M | $-168.35M | $895.00K | (m) | 12 month · $430.00K | (m) | (m) |
| 2025-09-30 | $0.00 | $11.00K | $168.98M | $-166.37M | $2.63M | (m) | 3 month · $77.00K | (m) | (m) |
| 2025-06-30 | $0.00 | $6.00K | $162.99M | $-164.88M | $-1.89M | (m) | 3 month · $98.00K | (m) | (m) |
| 2025-03-31 | $0.00 | $5.00K | $161.31M | $-162.83M | $-1.52M | (m) | 3 month · $170.00K | (m) | (m) |
| 2024-12-31 | $0.00 | $5.00K | $160.95M | $-160.12M | $837.00K | (m) | 12 month · $741.00K | (m) | (m) |
| 2024-09-30 | $0.00 | $5.00K | $160.57M | $-157.82M | $2.75M | 3 month · $926.00K | 3 month · $177.00K | (m) | (m) |
| 2024-06-30 | $0.00 | $2.00K | $154.12M | $-156.09M | $-1.96M | 3 month · $43.00K | 3 month · $184.00K | (m) | (m) |
| 2024-03-31 | $0.00 | $27.00K | $152.14M | $-154.44M | $-2.27M | 3 month · $43.00K | 3 month · $204.00K | (m) | (m) |
| 2023-12-31 | $0.00 | $2.00K | $150.57M | $-152.18M | $-1.60M | (m) | 12 month · $1.03M | (m) | (m) |
| 2023-09-30 | $0.00 | $22.00K | $149.42M | $-150.10M | $-660.00K | 3 month · $17.00K | 3 month · $251.00K | (m) | (m) |
| 2023-06-30 | $0.00 | $22.00K | $149.14M | $-147.53M | $1.64M | 3 month · $177.00K | 3 month · $317.00K | (m) | (m) |
| 2023-03-31 | $0.00 | $20.00K | $145.99M | $-144.10M | $1.90M | (m) | 3 month · $278.00K | (m) | (m) |
| 2022-12-31 | $0.00 | $20.00K | $145.48M | $-140.60M | $4.89M | 12 month · $162.00K | 12 month · $1.18M | (m) | (m) |
| 2022-09-30 | $0.00 | $18.00K | $141.66M | $-137.58M | $4.10M | 3 month · $1.00K | 3 month · $280.00K | (m) | (m) |
| 2022-06-30 | $0.00 | $18.00K | $141.24M | $-134.52M | $6.73M | 3 month · $232.00K 6 month · $232.00K | 3 month · $304.00K | 3 month · $271.00K | (m) |
| 2022-03-31 | $0.00 | $17.00K | $139.37M | $137.60M | $7.37M | (m) | 3 month · $319.00K | (m) | (m) |
| 2021-12-31 | $0.00 | $17.00K | $139.06M | $-128.70M | $10.38M | 12 month · $59.00K | 12 month · $1.66M | (m) | (m) |
| 2021-09-30 | $0.00 | $17.00K | $138.63M | $-125.24M | $13.41M | (m) | 3 month · $437.00K | (m) | (m) |
| 2021-06-30 | $0.00 | $17.00K | $138.19M | $-122.53M | $15.67M | (m) | 3 month · $384.00K | 3 month · $214.00K | (m) |
| 2021-03-31 | (m) | $17.00K | $137.59M | $-119.04M | $18.56M | 3 month · $67.00K 15 month · $67.00K | 3 month · $416.00K | (m) | (m) |
| 2020-12-31 | $0.00 | $16.00K | $135.23M | $-116.07M | $19.18M | (m) | 12 month · $2.95M | (m) | (m) |
| 2020-09-30 | (m) | $12.00K | $117.19M | $-113.08M | $4.11M | 3 month · $67.00K | 3 month · $737.00K | (m) | (m) |
| 2020-06-30 | (m) | $12.00K | $116.52M | $-109.24M | $7.29M | 3 month · $1.16M | 3 month · $655.00K | (m) | (m) |
| 2020-03-31 | (m) | $7.00K | $104.37M | $-105.66M | $-1.28M | (m) | 3 month · $941.00K | (m) | (m) |
| 2019-12-31 | (m) | $7.00K | $103.43M | $-101.07M | $2.37M | 12 month · $1.26M | 12 month · $2.72M | (m) | (m) |
| 2019-09-30 | (m) | $46.00K | $102.72M | $-97.57M | $5.19M | 3 month · $1.19M | 3 month · $756.00K | (m) | (m) |
| 2019-06-30 | (m) | $44.00K | $91.50M | $-93.78M | $-2.24M | (m) | 3 month · $696.00K | (m) | (m) |
| 2019-03-31 | (m) | $44.00K | $90.80M | $-90.03M | $818.00K | (m) | 3 month · $690.00K | (m) | (m) |
| 2018-12-31 | (m) | $5.00K | $90.15M | $-86.36M | $3.79M | 12 month · $200.00K | 12 month · $2.77M | (m) | (m) |
| 2018-09-30 | (m) | $38.00K | $85.62M | $-82.72M | $2.94M | (m) | 3 month · $730.00K | (m) | (m) |
| 2018-06-30 | (m) | $38.00K | $84.89M | $-79.17M | $5.76M | (m) | 3 month · $738.00K | (m) | (m) |
| 2018-03-31 | (m) | $38.00K | $84.16M | $-75.99M | $8.21M | (m) | 3 month · $615.00K | (m) | (m) |
| 2017-12-31 | $0.00 | $38.00K | $83.54M | $-72.45M | $11.12M | (m) | 12 month · $2.71M | (m) | (m) |
| 2017-09-30 | $0.00 | $38.00K | $82.71M | $-68.96M | $13.79M | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $458.00K | $81.59M | $-65.96M | $16.08M | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $458.00K | $80.91M | $-63.02M | $18.35M | (m) | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | $38.00K | $80.69M | $-60.14M | $20.58M | (m) | 12 month · $942.00K | (m) | (m) |
| 2016-09-30 | (m) | $231.00K | $25.78M | $-6.85M | $19.15M | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $230.00K | $25.77M | $-11.97M | $14.02M | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $230.00K | $25.77M | $-12.05M | $13.95M | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $19.00K | $341.00K | $-49.83M | $-3.44M | (m) | 12 month · $283.00K | (m) | (m) |
| 2015-09-30 | (m) | $230.00K | $25.77M | $-12.22M | $13.78M | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $230.00K | $25.77M | $-12.30M | $13.69M | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $230.00K | $25.77M | $-12.38M | $13.62M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $230.00K | $25.77M | $-12.13M | $-43.12M | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | $230.00K | $25.77M | $-12.52M | $13.48M | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $230.00K | $25.77M | $-12.56M | $13.44M | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $230.00K | $25.77M | $-12.71M | $13.37M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $230.00K | $25.77M | $-12.45M | $13.31M | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | $230.00K | $25.77M | $-12.71M | $13.30M | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $230.00K | $25.77M | $-12.71M | $13.27M | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $230.00K | $25.77M | $-12.71M | $13.27M | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $230.00K | $25.77M | $-12.71M | $13.29M | (m) | (m) | (m) | 12 month · $6.00K |
| 2012-09-30 | (m) | $230.00K | $25.82M | $-12.74M | $13.25M | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $230.00K | $25.81M | $-13.20M | $12.80M | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $230.00K | $25.81M | $-13.07M | $12.93M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $230.00K | $25.81M | $-13.01M | $12.98M | (m) | (m) | (m) | 12 month · $6.00K |
| 2011-09-30 | (m) | $230.00K | $25.80M | $-12.73M | $13.26M | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $230.00K | $25.80M | $-12.16M | $13.82M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $230.00K | $25.77M | $-22.67M | $3.28M | (m) | (m) | (m) | 12 month · $51.00K |
| 2009-12-31 | (m) | (m) | (m) | (m) | $14.74M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |